These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26161893)

  • 21. Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2014 May; 50(7):1361-9. PubMed ID: 24548766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
    J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment.
    Azuma K; Okamoto I; Kawahara A; Taira T; Nakashima K; Hattori S; Kinoshita T; Takeda M; Nakagawa K; Takamori S; Kuwano M; Ono M; Kage M
    J Thorac Oncol; 2012 Jan; 7(1):122-7. PubMed ID: 21892099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
    Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
    Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance.
    Yeo CD; Park GS; Kang N; Choi SY; Kim HY; Lee DS; Kim YS; Kim YK; Park JG; Sung SW; Lee KY; Park MS; Yim HW; Kim SJ; Lee JH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1365-70. PubMed ID: 25968616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients.
    Niemiec J; Kolodziejski L; Dyczek S
    Neoplasma; 2005; 52(3):231-7. PubMed ID: 15875085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERCC1 expression correlated with EGFR and clinicopathological variables in patients with non-small cell lung cancer. An immunocytochemical study on fine-needle aspiration biopsies samples.
    Kalogeraki A; Karvela-Kalogeraki I; Tamiolakis D; Petraki P; Saridaki Z; Tzardi M
    Rev Port Pneumol; 2014; 20(4):200-7. PubMed ID: 24508180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
    Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.
    Al Zobair AA; Al Obeidy BF; Yang L; Yang C; Hui Y; Yu H; Zheng F; Yang G; Xie C; Zhou F; Zhou Y
    Oncol Rep; 2013 Apr; 29(4):1524-32. PubMed ID: 23443279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.
    Sun Y; Han Y; Wang X; Wang W; Wang X; Wen M; Xia J; Xing H; Li X; Zhang Z
    Oncol Rep; 2016 Aug; 36(2):1030-40. PubMed ID: 27350337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
    Zhou SJ; Xu SF; Zhang HQ; Liu ZD
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival.
    Veale D; Kerr N; Gibson GJ; Kelly PJ; Harris AL
    Br J Cancer; 1993 Jul; 68(1):162-5. PubMed ID: 8391303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.
    Sterlacci W; Fiegl M; Hilbe W; Jamnig H; Oberaigner W; Schmid T; Augustin F; Auberger J; Obermann EC; Tzankov A
    J Thorac Oncol; 2010 Sep; 5(9):1325-36. PubMed ID: 20631637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
    Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
    Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
    Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
    Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.